LakeMountD
Doctor Science
Invalid Link Removed
This isn't all that big of a deal but it is still an interesting article, especially in the area of cancer research. IGF-1 LR3 is unable to bind to IGF-1-BP3 anyways so there isn't much of a concern for those who take IGF-1 LR3 exogenously.
This isn't all that big of a deal but it is still an interesting article, especially in the area of cancer research. IGF-1 LR3 is unable to bind to IGF-1-BP3 anyways so there isn't much of a concern for those who take IGF-1 LR3 exogenously.
Last edited: